Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Global Public Health Research Foundation | OTHER |
Not provided
Not provided
Not provided
Not provided
Tobacco use remains persistently high across South Asia, despite numerous public health efforts, and continues to significantly contribute to the burden of non-communicable diseases (NCDs) such as cardiovascular disease, hypertension, diabetes, and stroke. Community pharmacists-widely accessible and trusted within their communities-are an underutilized resource for delivering public health interventions. Graphic health warnings (GHWs), recommended by the World Health Organization (WHO), have been shown to promote smoking cessation, but are rarely paired with personalized counseling by healthcare providers.
This study aims to evaluate both the effectiveness and cost-effectiveness of integrating GHWs with pharmacist-led personalized counseling at primary healthcare pharmacies in Bangladesh and Pakistan. A cluster randomized controlled trial (RCT) will be conducted, enrolling 3,240 adult participants in Bangladesh and ~160 participants in Pakistan (for feasibility study) from community pharmacies. Participants will be randomly assigned to one of three groups: (1) GHW only (distribution of printed booklets); (2) GHW + counseling (pharmacist-led counselling sessions based on booklets at baseline and six months, with monthly SMS reminders); or (3) standard care (usual pharmacy services with no additional materials).
The intervention includes twice-yearly counseling sessions-delivered both in-person and digitally-supported by educational booklets and leaflets. The primary outcome is self-reported 7-day point prevalence abstinence at 12 months (validated where feasible). Secondary outcomes include reduction in cigarettes per day, quit attempts, readiness to quit, awareness of tobacco harms, diet and physical activity scores, quality of life, blood pressure control among hypertensive participants, and cost-effectiveness. Feasibility outcomes in Pakistan include recruitment rate, participant retention, intervention fidelity and acceptability. Bayesian statistical models will be used to assess efficacy, and economic evaluations will determine the cost-effectiveness of the interventions. The findings aim to inform scalable public health strategies for tobacco control and NCD prevention in resource-limited settings.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| GHW-only intervention | Experimental | This group will receive only graphical health warnings (GHWs) featuring images proposed by the Bangladesh Tobacco Control Cell, explicitly illustrating smoking-related harms, such as mouth diseases, damaged teeth and gums, lung diseases and cancer, heart diseases and cardiovascular damage, and throat and oral cancer. Additionally, these warnings will clearly highlight the benefits of quitting smoking-including improved overall health, reduced disease risks, financial savings, and enhanced quality of life-as well as practical cessation techniques. Participants will receive these GHW materials at baseline and again at the six-month follow-up to reinforce these critical health messages; however, this intervention group will not receive any counselling services. Monthly SMS reminders will also be sent to participants, prompting them to review the GHW leaflet and reinforcing the negative health impacts of smoking and the benefits of quitting. |
|
| GHW plus pharmacist-led counselling | Experimental | Participants in this group will receive graphical health warnings (GHWs) featuring Bangladesh Tobacco Control Cell-approved images clearly depicting smoking-related harms (e.g., mouth diseases, damaged teeth and gums, lung cancer, heart disease, and oral cancer). Additionally, they will receive personalized counselling from community pharmacists, focused on the specific health and financial benefits of quitting, practical cessation techniques, strategies for overcoming barriers, and relapse prevention. This combined intervention will be provided at baseline and reinforced at a six-month follow-up. Monthly SMS reminders will also be sent, reinforcing key messages on the harmful effects of smoking and benefits of cessation. |
|
| Standard care control | Active Comparator |
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Graphical health warnings | Behavioral | This group will receive only graphical health warnings (GHWs) featuring images proposed by the Bangladesh Tobacco Control Cell, explicitly illustrating smoking-related harms, such as mouth diseases, damaged teeth and gums, lung diseases and cancer, heart diseases and cardiovascular damage, and throat and oral cancer. Additionally, these warnings will clearly highlight the benefits of quitting smoking-including improved overall health, reduced disease risks, financial savings, and enhanced quality of life-as well as practical cessation techniques. Participants will receive these GHW materials at baseline and again at the six-month follow-up to reinforce these critical health messages; however, this intervention group will not receive any counselling services. Monthly SMS reminders will also be sent to participants, prompting them to review the GHW leaflet and reinforcing the negative health impacts of smoking and the benefits of quitting. |
| Measure | Description | Time Frame |
|---|---|---|
| Self-reported 7-day point prevalence abstinence | The primary outcome is self-reported 7-day point prevalence abstinence at 12 months. Will be measured by percentage of participants who report smoking cessation | 6 months and 12 months post-intervention. |
| Measure | Description | Time Frame |
|---|---|---|
| Change in Cigarette Consumption | Change in the number of cigarettes smoked per day among participants from baseline.medication adherence. | 6 and 12 months. |
| Quit Attempts | Proportion of participants reporting at least one quit attempt during the follow-up period.medication adherence. |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Md. Mizanur Rahman, PhD | Contact | +818035463610 | mizanurrub78@gmail.com |
| Name | Affiliation | Role |
|---|---|---|
| Md. Mizanur Rahman | Hitotsubashi University | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Global Public Health Research Foundation | Recruiting | Dhaka | Bangladesh |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D020340 | Tobacco Use Cessation |
| D006973 | Hypertension |
| D000073296 | Noncommunicable Diseases |
| ID | Term |
|---|---|
| D015438 | Health Behavior |
| D001519 | Behavior |
| D014652 | Vascular Diseases |
| D002318 | Cardiovascular Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Participants in this group will receive only routine pharmacy services based on standard pharmacy practice guidelines applicable in each country. They will not receive any additional graphical health warnings or counselling interventions. Outcomes will be assessed at baseline, 6 months, and 12 months, consistent with the intervention groups.
|
|
| Graphical health warnings plus pharmacist-led counselling | Behavioral | Participants in this group will receive graphical health warnings (GHWs) featuring Bangladesh Tobacco Control Cell-approved images clearly depicting smoking-related harms (e.g., mouth diseases, damaged teeth and gums, lung cancer, heart disease, and oral cancer). Additionally, they will receive personalized counselling from community pharmacists, focused on the specific health and financial benefits of quitting, practical cessation techniques, strategies for overcoming barriers, and relapse prevention. This combined intervention will be provided at baseline and reinforced at a six-month follow-up. Monthly SMS reminders will also be sent, reinforcing key messages on the harmful effects of smoking and benefits of cessation. |
|
| Routine pharmacy services (no intervention) | Other | Participants in this group will receive only routine pharmacy services based on standard pharmacy practice guidelines applicable in each country. They will not receive any additional graphical health warnings or counselling interventions. Outcomes will be assessed at baseline, 6 months, and 12 months, consistent with the intervention groups. |
|
| 6 and 12 months. |
| Readiness to Quit Smoking | Change in participants' readiness to quit smoking, assessed using stages of change or validated readiness scales. | 6 and 12 months. |
| Improvement in Knowledge About Smoking Harms | Percentage increase in correct responses to questions on the health effects of smoking. | 6 and 12 months. |
| Improved Hypertension Management | Proportion of hypertensive participants achieving BP <140/90 mmHg or reporting medication adherence. | 6 and 12 months. |
| Improved Diabetes Management | Proportion of participants with diabetes reporting glucose monitoring, medication adherence, or controlled HbA1c (if available). | 6 and 12 months. |
| Change in Quality-Adjusted Life Years (QALYs) | Incremental QALYs gained from baseline to 12 months, based on health utility measures (e.g., EQ-5D).stroke, cardiac events). | 6 and 12 months. |
| Hospital Admissions | Number of participants reporting hospital admission related to NCDs (e.g., hypertension, stroke, cardiac events). | 6 and 12 months. |
| Increase in Physical Activity | Increase in days per week with at least 30 minutes of moderate activity. | 6 and 12 months. |
| Diet Quality | Change in dietary behaviour assessed using a composite diet quality score based on frequency and type of food consumption (e.g. fruit, vegetables, processed foods). | 6 and 12 months. |
| Incremental Cost-Effectiveness Ratio | Cost per QALY gained comparing intervention arms to control. | At 12 months. |
| Image-Based Biomarker Assessment (Exploratory Secondary Outcome) | Quantitative features extracted from facial photographs, eye photographs, and chest X-rays will be analyzed to examine associations with smoking exposure, blood pressure, and cardiometabolic risk markers. | Time Frame: Baseline and 12 months. |
| D020969 |
| Disease Attributes |
| D010335 | Pathologic Processes |
| D013568 | Pathological Conditions, Signs and Symptoms |